TWO SIGMA INVESTMENTS, LP - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 122 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$1,398,000
-50.1%
41,370
-70.1%
0.00%
-70.0%
Q3 2020$2,804,000
-32.7%
138,380
-0.1%
0.01%
-52.4%
Q2 2020$4,164,000
+678.3%
138,580
+713.4%
0.02%
+425.0%
Q1 2020$535,000
-80.7%
17,037
-71.0%
0.00%
-50.0%
Q4 2019$2,772,00058,8350.01%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2020
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders